LifeScience Emerging Biotech
Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...
March 06, 2024 | News
YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, announced the Center for Drug Evaluation ...
March 05, 2024 | News
Collaboration leverages Neomorph's leading molecular glue discovery platform and Novo Nordisk's extensive expertise in cardiometabolic and rare diseases ...
March 27, 2024 | News
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...
February 26, 2024 | News
RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...
February 22, 2024 | News
Hox Therapeutics Ltd, a pioneering biotechnology company dedicated to developing targeted cancer therapies, and Vernalis (R&D) Ltd, a renowned subsidia...
February 22, 2024 | News
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a leading biotechnology company, announced a significant coll...
February 20, 2024 | News
AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products&...
February 19, 2024 | News
Pharus Diagnostics ("PharusDx") has announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be...
February 16, 2024 | News
In a strategic move towards sustainable innovation, Cathay Biotech Inc. of China and 3P.COM Co. Limited of South Korea have signed a landmark joint venture...
February 09, 2024 | News
This groundbreaking achievement marks mazdutide as the first GLP-1R/GCGR dual agonist to successfully complete Phase 3 trials in support of an NDA ...
February 08, 2024 | Regulatory
The collaboration will focus on ensuring compatibility between seqWell-developed products and the entire Complete Genomics next-generation sequencing (NGS)...
February 08, 2024 | News
In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...
January 26, 2024 | Interview
Most Read
Bio Jobs
News
Editor Picks